Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-tumor gene therapy

C Cirielli1, M C Capogrossi, A Passaniti

  • 1Laboratorio di Patologia Vascolare, IDI, Rome, Italy.

Journal of Neuro-Oncology
|January 1, 1997
PubMed
Summary

Gene therapy utilizes advanced delivery systems for anti-tumor cytokine delivery, offering new hope for difficult-to-treat cancers like neuroendocrine tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miR-200c inhibition and catalase accelerate diabetic wound healing.

Journal of biomedical science·2025
Same author

The Oxidative Stress-Induced miR-200c Is Upregulated in Psoriasis and Correlates with Disease Severity and Determinants of Cardiovascular Risk.

Oxidative medicine and cellular longevity·2020
Same author

Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy.

European heart journal·2015
Same author

Cyclophilin A: a key player for human disease.

Cell death & disease·2013
Same author

High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV.

Diabetologia·2011
Same author

miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition.

Cell death and differentiation·2011

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Gene therapy is an emerging anti-tumor strategy using cytokine delivery to inhibit tumor growth.
  • Various delivery systems, including liposomes and viral vectors, are being developed for therapeutic gene expression.

Purpose of the Study:

  • To review current gene therapy strategies for anti-tumor treatment.
  • To discuss the potential of novel expression vectors for targeted cancer therapy.

Main Methods:

  • Review of existing literature on gene therapy delivery systems (liposomes, retroviral, adenoviral vectors).
  • Discussion of gene-targeting strategies, including oncogene inactivation (e.g., ras) and tumor suppressor gene re-expression (e.g., p53).
  • Exploration of exogenous gene applications, such as viral thymidine kinase for chemotherapeutic activation.

Main Results:

  • Current delivery systems show promise but clinical application depends on tumor type, location, gene, and patient status.
  • Novel vectors aim for tissue-specific targeting and reduced immune response.
  • Gene therapy strategies are particularly relevant for challenging tumors like neuroendocrine cancers.

Conclusions:

  • Gene therapy offers a powerful approach to inhibit tumor growth, especially for difficult-to-treat cancers.
  • Advances in vector design are crucial for achieving safe and effective tumor targeting.
  • Future developments may expand the application of gene therapy to a wider range of malignant tumors.

Related Experiment Videos